Vimarsana
Biggest News Aggregation in the World

Page 3 - Epithelial Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epithelial Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epithelial Cells Today - Breaking & Trending Today

EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395 - Vimarsana News

EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395

Regulatory approval for proof of pharmacology study for the first non-antibiotic macrolideREYKJAVIK, Iceland, August 31, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received...

Successful Completion of Phase I Study for Lead Asset EP395 - Vimarsana News

Successful Completion of Phase I Study for Lead Asset EP395

First non-antibiotic macrolide to go into clinical development – targeting COPDSafety, tolerability and pharmacokinetic endpoints metPhase II planning underwayREYKJAVIK, Iceland, May 18, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modi...

EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial - Vimarsana News

EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial

REYKJAVIK, Iceland, March 24, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2022. EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment...

Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study - Vimarsana News

Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study

Corantin Maurin and colleagues investigate the capacity of human cornea to be infected by SARS-CoV-2 virus and evidence for viral detection in corneas from donors with a positive test for SARS-CoV-2 infection.

Source: plos.org
SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles - Vimarsana News

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.